Physician profile
Dean W Singer
NPI 1972504918
$17,573.24
in general payments reported to CMS, 2019-2025
50 companies · $3,745 in 2025
The $3,745 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,986 · 2020: $1,388 · 2021: $1,501 · 2022: $2,530 · 2023: $3,678 · 2024: $2,745 · 2025: $3,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,167.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,913.85 | 2019-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Horizon Therapeutics Plc | $1,929.56 | 2019-2023 | Krystexxa |
| Stryker Corporation | $1,736.61 | 2021-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Allomatrix |
| Progenacare Global, LLC | $1,581.40 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $978.42 | 2021-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $927.29 | 2019-2025 | Na, N/A, Hammerlock |
| Bioventus LLC | $807.32 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Stimrouter Implantable Kit |
| Kerecis Limited | $650.60 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Abbvie INC. | $559.98 | 2019-2025 | Dalvance |
| Melinta Therapeutics, LLC | $550.07 | 2019-2023 | Kimyrsa |
| Osteomed LLC | $539.24 | 2020-2022 | |
| Treace Medical Concepts, INC. | $529.30 | 2022-2025 | |
| Organogenesis INC. | $510.75 | 2019-2025 | Novachor |
| Paragon 28, INC. | $486.17 | 2020-2024 | Portfolio, Ttc Nail |
| Nevro Corp. | $340.98 | 2023-2024 | Senza |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.